Skip to main content
Premium Trial:

Request an Annual Quote

AxCell Licenses ProChart Data to NCI for Prostate Cancer Research

NEW YORK, June 18 - AxCell Biosciences said today it will give the National Cancer Institute access to part of its ProChart database to help it research a prostate cancer-suppressor gene.


The deal, announced in a Letter of Intent, calls for the NCI to give AxCell certain biological and biochemical data about the oncogene, which encodes for a protein containing an SH3 domain-binding ligand. In exchange, AxCell, a unit of biotech firm Cytogen, will give the NCI SH3 domain-interaction data from its ProChart tool.


Click here for more information.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.